Related Experiment Video
Updated: Jul 6, 2025

Visualization of Vascular Ca2+ Signaling Triggered by Paracrine Derived ROS
Published on: December 21, 2011
Emodin alleviates CRS4-induced mitochondrial damage via activation of the PGC1α signaling
Xin Dong1,2,3, Ruijia Wen1,2,3, Yuanyuan Xiong1,2,3
1The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China.
Insights
Emodin, a natural compound, protects the heart in cardiorenal syndrome type 4 (CRS4) by reducing kidney damage and improving cardiac function. It works by activating PGC1α signaling, mitigating mitochondrial damage in chronic kidney disease (CKD).
Area of Science:
- Nephrology
- Cardiology
- Mitochondrial Biology
Background:
- Cardiorenal syndrome type 4 (CRS4) is a severe complication of chronic kidney disease (CKD), leading to significant cardiac dysfunction and mortality.
- Understanding the mechanisms underlying CRS4 is crucial for developing effective therapeutic interventions.
Purpose of the Study:
- To investigate the potential cardioprotective effects of emodin in a mouse model of CRS4.
- To elucidate the molecular pathways, particularly PGC1α signaling, involved in emodin's protective action.
Main Methods:
- In vivo studies utilized a 5/6 nephrectomy mouse model to simulate CRS4.
- In vitro experiments involved HL-1 cells exposed to CKD mouse serum.
- Comprehensive assessments included echocardiography, histological analysis, immunofluorescence, biochemical assays, flow cytometry, qPCR, and Western blotting.
Main Results:
- Emodin demonstrated protective effects on both kidney function/structure and cardiac morphology/function in the CRS4 model.
- Emodin suppressed reactive oxygen species production and mitochondrial oxidative damage while enhancing oxidative metabolism.
- These benefits were linked to the restoration of PGC1α expression and its downstream targets, with PGC1α inhibition reversing the cardioprotective effects.
Conclusions:
- Emodin confers cardioprotection against 5/6 nephrectomy-induced mitochondrial damage in CRS4 by activating PGC1α signaling.
- These findings suggest emodin as a potential therapeutic agent for managing CRS4 patients.
Abstract:
Cardiorenal syndrome type 4 (CRS4), a progressive deterioration of cardiac function secondary to chronic kidney disease (CKD), is a leading cause of death in patients with CKD. In this study, we aimed to investigate the cardioprotective effect of emodin on CRS4. C57BL/6 mice with 5/6 nephrectomy and HL-1 cells stimulated with 5% CKD mouse serum were used for in vivo and in vitro experiments. To assess the cardioprotective potential of emodin, we employed a comprehensive array of methodologies, including echocardiography, tissue staining, immunofluorescence staining, biochemical detection, flow cytometry, real-time quantitative PCR, and western blot analysis. Our results showed that emodin exerted protective effects on the function and structure of the residual kidney. Emodin also reduced pathologic changes in the cardiac morphology and function of these mice. These effects may have been related to emodin-mediated suppression of reactive oxygen species production, reduction of mitochondrial oxidative damage, and increase of oxidative metabolism via restoration of PGC1α expression and that of its target genes. In contrast, inhibition of PGC1α expression significantly reversed emodin-mediated cardioprotection in vivo. In conclusion, emodin protects the heart from 5/6 nephrectomy-induced mitochondrial damage via activation of the PGC1α signaling. The findings obtained in our study can be used to develop effective therapeutic strategies for patients with CRS4.
Related Concept Videos
Regulation of the Unfolded Protein Response
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Intrinsic Apoptotic Pathway
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
The Unfolded Protein Response
Mitochondrial Membranes

